Burden and Predictors of Statin Use for Primary and Secondary Prevention of Cardiovascular Disease in Bangladesh: Evidence from a Nationally Representative Survey
References
- World Health Organization. Cardiovascular diseases (CVDs) [Internet]. [cited 2024 Sep 3]. Available from:
https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) - GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Lond Engl. 2017 Sep 16;390(10100):1151–1210.
- Armitage J, Baigent C, Barnes E, Betteridge DJ, Blackwell L, Blazing M, et al. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials. The Lancet. 2019;393(10170):407–415. DOI: 10.1016/S0140-6736(18)31942-1
- Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. The Lancet. 2016;388(10059):2532–2561. DOI: 10.1016/S0140-6736(16)31357-5
- World Health Organization. WHO package of essential noncommunicable (PEN) disease interventions for primary health care [Internet]. [cited 2024 Sep 3]. Available from:
https://www.who.int/publications/i/item/9789240009226 - Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(24):3168–3209. DOI: 10.1016/j.jacc.2018.11.002
- Yusuf S, Islam S, Chow CK, Rangarajan S, Dagenais G, Diaz R, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): A prospective epidemiological survey. The Lancet. 2011;378(9798):1231–1243. DOI: 10.1016/S0140-6736(11)61215-4
- Wong ND, Young D, Zhao Y, Nguyen H, Caballes J, Khan I, et al. Prevalence of the American College of Cardiology/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011–2012. J Clin Lipidol. 2016;10(5):1109–1118. DOI: 10.1016/j.jacl.2016.06.011
- Marcus ME, Manne-Goehler J, Theilmann M, Farzadfar F, Moghaddam SS, Keykhaei M, et al. Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data. Lancet Glob Health. 2022;10(3):e369–79. DOI: 10.1016/S2214-109X(21)00551-9
- Chow CK, Nguyen TN, Marschner S, Diaz R, Rahman O, Avezum A, et al. Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries. 2020 [cited 2024 Sep 4]; Available from:
https://gh.bmj.com/content/5/11/e002640.long . DOI: 10.1136/bmjgh-2020-002640 - World Population Review. Bangladesh Population 2024 (Live) [Internet]. [cited 2024 Sep 4]. Available from:
https://worldpopulationreview.com/countries/bangladesh - Islam SMS, Uddin R, Das S, Ahmed SI, Zaman SB, Alif SM, et al. The burden of diseases and risk factors in Bangladesh, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Glob Health. 2023;11(12):e1931–e1942. DOI: 10.1016/S2214-109X(23)00432-1
- World Health Organization. Bangladesh – STEPS 2018 [Internet]. [cited 2024 Sep 1]. Available from:
https://extranet.who.int/ncdsmicrodata/index.php/catalog/770 - Monower MM, Abid SUA, Abrar AK, Choudhury SR. Salt intake across the hypertension care cascade in the Bangladeshi adult population: A nationally representative cross-sectional study. 2024 [cited 2024 Sep 1]; Available from:
https://bmjopen.bmj.com/content/14/4/e081913.long#ref-12 . DOI: 10.1136/bmjopen-2023-081913 - Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502. DOI: 10.1093/clinchem/18.6.499
- Kaptoge S, Pennells L, De Bacquer D, Cooney MT, Kavousi M, Stevens G, et al. World Health Organization cardiovascular disease risk charts: Revised models to estimate risk in 21 global regions. Lancet Glob Health. 2019;7(10):e1332–1345.
- CRAN R. Jaeger B. PooledCohort: Predicted Risk for CVD using Pooled Cohort Equations, PREVENT Equations, and Other Contemporary CVD Risk Calculators [Internet]. 2021 [cited 2024 Sep 5]. p. 0.0.2. Available from:
https://CRAN.R-project.org/package=PooledCohort . DOI: 10.32614/CRAN.package.PooledCohort - Thompson WD, Walter SD. A reappraisal of the kappa coefficient. J Clin Epidemiol. 1988;41(10):949–958. DOI: 10.1016/0895-4356(88)90031-5
- Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–174. DOI: 10.2307/2529310
- Zou G. A Modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–706. DOI: 10.1093/aje/kwh090
- Mortensen MB, Nordestgaard BG. Comparison of five major guidelines for statin use in primary prevention in a contemporary general population. Ann Intern Med. 2018;168(2):85. DOI: 10.7326/M17-0681
- Pencina MJ, Navar-Boggan AM, D’Agostino RB, Williams K, Neely B, Sniderman AD, et al. Application of new cholesterol guidelines to a population-based sample. N Engl J Med. 2014;370(15):1422–1431. DOI: 10.1056/NEJMoa1315665
- National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–3421. DOI: 10.1161/circ.106.25.3143
- Nanna MG, Wang TY, Xiang Q, Goldberg AC, Robinson JG, Roger VL, et al. Sex differences in the use of statins in community practice: patient and provider assessment of lipid management registry. Circ Cardiovasc Qual Outcomes. 2019;12(8):
e005562 . DOI: 10.1161/CIRCOUTCOMES.118.005562 - NHLBI, NIH. Blood Cholesterol – Diagnosis | NHLBI, NIH [Internet]. [cited 2024 Sep 10]. Available from:
https://www.nhlbi.nih.gov/health/blood-cholesterol/diagnosis - Kanaya AM, Herrington D, Vittinghoff E, Ewing SK, Liu K, Blaha MJ, et al. Understanding the high prevalence of diabetes in U.S. south Asians compared with four racial/ethnic groups: The MASALA and MESA studies. Diabetes Care. 2014;37(6):1621–1628. DOI: 10.2337/dc13-2656
- Mach F, Ray KK, Wiklund O, Corsini A, Catapano AL, Bruckert E, et al. Adverse effects of statin therapy: Perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract. Eur Heart J. 2018;39(27):2526–2539. DOI: 10.1093/eurheartj/ehy182
- Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J. 2016;37(39):2999–3058. DOI: 10.1093/eurheartj/ehw272
- Butalia S, Lee-Krueger RCW, McBrien KA, Leung AAC, Anderson TJ, Quan H, et al. Barriers and facilitators to using statins: A qualitative study with patients and family physicians. CJC Open. 2020;2(6):530–538. DOI: 10.1016/j.cjco.2020.07.002
- Khatib R, McKee M, Shannon H, Chow C, Rangarajan S, Teo K, et al. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: An analysis of the PURE study data. Lancet Lond Engl. 2016;387(10013):61–69. DOI: 10.1016/S0140-6736(15)00469-9
- Hafferty JD, Campbell AI, Navrady LB, Adams MJ, MacIntyre D, Lawrie SM, et al. Self-reported medication use validated through record linkage to national prescribing data. J Clin Epidemiol. 2018;94:132–142. DOI: 10.1016/j.jclinepi.2017.10.013
DOI: https://doi.org/10.5334/gh.1412 | Journal eISSN: 2211-8179
Language: English
Submitted on: Oct 18, 2024
Accepted on: Feb 24, 2025
Published on: Mar 12, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2025 Shehab Uddin Al Abid, Md Mostafa Monower, Ahmad K. Abrar, Jannat A. Riva, Mahfuzur Rahman Bhuiyan, Mohammad Abdullah Al-Mamun, Sohel Reza Choudhury, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.